We're proud to share that Hilary Gentile, Chief of Commercial Strategy and Innovation at BGBx Consulting has been recognised as an ELITE 2026 Strategist by PM360 Magazine! Across more than two decades in healthcare and life sciences, Hilary has built a reputation for anticipating shifts before they materialize. At BGBx Consulting, Hilary brings together strategy, innovation, and intelligence in developing AI-driven, proprietary tools that unlock insight into healthcare decision-making. This well-deserved recognition reflects the strategic leadership, expertise, and thoughtful guidance Hilary brings to clients, teams, and the broader healthcare industry. Read more about Hilary's recognition here: https://lnkd.in/ebpnrxJK Congratulations, Hilary, on this outstanding achievement. We're delighted to see your leadership recognised. #PM360 #HealthcareMarketing #Strategy #Innovation
Kx Advisors
Business Consulting and Services
Washington, District of Columbia 19,969 followers
About us
For more than 40 years, Kx Advisors (operating as Kaiser Associates’ Healthcare Practice) has provided strategy consulting services to help healthcare executives achieve critical business growth goals. With a highly collaborative approach they have developed pragmatic solutions for leading pharmaceutical, biotechnology, medical device, health IT, digital health, and diagnostics clients, with data-driven insights to give those clients the tools to compete and win across the healthcare industry.
- Website
-
http://www.kxadvisors.com
External link for Kx Advisors
- Industry
- Business Consulting and Services
- Company size
- 51-200 employees
- Headquarters
- Washington, District of Columbia
- Type
- Privately Held
- Specialties
- Pharmaceuticals, Medical device, Diagnostics, Life sciences, Digital health, Health IT, Mergers and acquisitions, Pricing, Market access, Portfolio planning, Healthcare, Medical Technology, Strategy Consulting, and Product Launch
Employees at Kx Advisors
Locations
-
Primary
Get directions
1300 Connecticut Ave NW
Washington, District of Columbia 20036, US
-
Get directions
1 Triton Square
London, England NW1, GB
-
Get directions
100 Summer St
16th Floor
Boston, Massachusetts 02110, US
-
Get directions
250 W 34th St
New York, NY 10001, US
Updates
-
We are excited to announce that Kx is now part of BGBx Consulting, bringing together Kx Advisors, Hayden Consulting Group, and the BGB Group Innovation & Intelligence team. This evolution strengthens our ability to support clients by combining deep strategic expertise, innovative thinking, and industry-leading insights under one consulting division. While our name is changing, the trusted team, specialized expertise, and client-focused approach that have defined Kx Advisors remain the same. As part of BGBx Consulting, our clients will benefit from broader capabilities, diverse perspectives, and expanded resources to help navigate the healthcare industry's most complex challenges. We look forward to this exciting new chapter as BGBx Consulting and continuing to partner with our clients to drive meaningful impact.
-
-
Join us at the Annual EULAR - European Alliance of Associations for Rheumatology Meeting. Connect with Kx Advisors leader, Chloe Lok to learn more about what's next in the ever-evolving world of #rheumatology. #EULAR2026
-
-
📣 Kx Advisors are hiring! We're growing our team and would love to connect with curious, motivated people who are interested in working on meaningful, real-world challenges across healthcare. Learn more about current openings here: 👉 https://lnkd.in/eVAGyDr
-
-
Kx Advisors reposted this
I know I've been a bit MIA but I'm here to share in #SumUpSaturday on #VBC and #reimbursement in #MSK! In case you didn't hear, at the start of the week, CMS kind of quietly announced that starting in 2027 ALL Medicare lower extremity joint arthroplasty in the hospital (hip, knee AND ankle) will be subject to bundled payments... this is in addition to TEAMs. My go to VBC expert Benjamin Schwartz, MD, MBA first shared this post below. Christian explains it better than I could. This raises a lot of questions and challenges in an already cost contained environment. Arguably, this further supresses surgeon autonomy and decision making. While innovation will likely be evaluated by VACs with a broader lens, scrutiny on ability to reduce costs, not just improve workflows and outcomes will be even higher. Will share more thoughts as I work through the implications. Meanwhile, CMS and FDA announced their 3rd iteration of breakthrough device reimbursement to replace TCIT named RAPID. Is 3rd time a charm? https://lnkd.in/e4HumGMC
Executive Director of AI and IT Innovation at Duke Orthopedic Surgery, Orthopedic Trauma Surgeon | CEO and Co-Founder of RevelAi Health
On October 1, 2027, essentially every IPPS hospital in the United States that isn't already in TEAM will be mandatorily at 90-day episode risk for hip, knee, and ankle replacement. CJR-X is the most aggressive expansion of mandatory episode-based payment in the history of the Innovation Center. The original CJR model ran in 67 MSAs from 2016 to 2024 and generated $112.7M in net Medicare savings across 98,000 episodes at 323 hospitals while maintaining quality. CMS read that result and concluded, reasonably, that the intervention works. CJR-X takes it nationwide, bolts on outpatient LEJR and total ankle, keeps the 90-day window, adds a quality-first composite score gate, a 5% stop-loss for dual-eligible-heavy hospitals, 29 risk adjusters, and a waiver of the SNF 3-day stay rule. Projected 5-year savings: $725M. Read it alongside TEAM and the doubling down on accountable care seems more steadfast. TEAM holds 729 hospitals accountable for 30-day surgical episodes starting this year. CJR-X picks up almost everyone else for 90-day joint replacement episodes starting late 2027. Together they represent something CMS has never done before: near-universal mandatory episode risk for orthopedic surgery. This lands at a difficult moment. Primary TJA reimbursement is down 56% since 2000. The 2026 Physician Fee Schedule added another 2.5% efficiency cut on surgical procedures. Demand is projected to nearly triple by 2040. You cannot keep compressing procedural payment on the most cost-effective intervention in all of medicine and simultaneously expand episode accountability without building new infrastructure to capture value beyond the cut. Benjamin Schwartz, MD, MBA and I are going to dig in on the model Thursday: → What does CJR-X change for hospitals already thinking about TEAM — and what does it mean for the ones that assumed mandatory bundles wouldn't reach them? → Where does the 90-day window create real operational opportunity (post-acute navigation, PT partnerships, readmission prevention) versus where it creates brittle risk for hospitals without the infrastructure to manage it? → How do we think about gainsharing, physician alignment, and the role of ASCs and HOPDs as outpatient LEJR volume keeps migrating? Going live Thursday on the Techy Surgeon Substack with Benjamin Schwartz, MD, MBA to dive in on the model and discuss the shifting incentives of musculoskeletal care. If you're an orthopedic surgeon, hospital CFO, a service-line leader, or anyone trying to make sense of where MSK value-based care is actually heading — come join us. A reminder, public comment on CJR-X closes June 9. (Also if you haven't checked out the new Chat GPT Image module it's pretty incredible and made the anime portrait of us below).
-
-
As the MedTech capital landscape continues to evolve, staying ahead requires the right insight partners. Join Kx Advisors in Boston at this year's MedTech Capital Connect Conference hosted by Private Capital Global and connect with MedTech expert, Masha Dumanis to explore how we're helping companies navigate change and drive sustainable growth. #MedTechCapitalConnect #GrowthStrategy
-
-
Kx Advisors reposted this
In today’s fast-evolving, resource-constrained healthcare landscape, successful start-up commercialization requires more than just great science. 💭 Jenny Knauss, PhD, Vice President at Kx Advisors, a BGB Group Company shares her perspective on key elements for commercial success - from selecting the right agency partners to the evolving role of AI and data-driven marketing in the latest PM360 Magazine Think Tank. 👉 Read the full article here (page 42): https://lnkd.in/evuUrXEx Interested in discussing these themes further? 📧 Contact Jenny at jenny.knauss@kxadvisors.com
-
-
In today’s fast-evolving, resource-constrained healthcare landscape, successful start-up commercialization requires more than just great science. 💭 Jenny Knauss, PhD, Vice President at Kx Advisors, a BGB Group Company shares her perspective on key elements for commercial success - from selecting the right agency partners to the evolving role of AI and data-driven marketing in the latest PM360 Magazine Think Tank. 👉 Read the full article here (page 42): https://lnkd.in/evuUrXEx Interested in discussing these themes further? 📧 Contact Jenny at jenny.knauss@kxadvisors.com
-
-
🎉 We're delighted to announce the promotion of Chris Waybill to Partner. This milestone reflects Chris's leadership, deep expertise, and the meaningful impact he continues to deliver for our clients and teams. Congratulations on this well-deserved achievement - thank you for your commitment to Kx, we celebrate your success!
-
-
Kx Advisors is proud to be recognised again as a top firm to work for in the 2026 Vault Consulting rankings! 🏆 Top 50 Consulting Firms in North America 🌍 Top 25 Consulting Firms in EMEA ✨ Kx ranked within the Top 10 across key areas that matter most to our people and clients including firm leadership, culture, promotion policies, training & client interaction. 👩💼 We’re especially proud to be ranked #7 Best Consulting Firm for Women — a recognition that reflects our ongoing commitment to inclusion, equity, and growth at every level. Thank you to our Kx colleagues for shaping a culture we’re proud of, and to our clients for our continued collaboration and partnerships. 👉 See our full Vault rankings linked in the comments below. #VaultRankings #Consulting